Cytori Therapeutics Inc., of Austin, Texas, has changed its name to Plus Therapeutics Inc. Its ticker symbol on the Nasdaq Capital Market and for its series S warrants is now PSTV. The company plans a 1-for-50 reverse stock split on Aug. 5. The number of outstanding shares of its common stock is anticipated to change from about 22.2 million to approximately 400,000.